… alterations in patients with COVID‐19 compared with uninfected controls in this study.
Our results refine the molecular view of COVID‐19 pathophysiology associated with disease …

… test results from 28 COVID-19 patients. The concentrations of 6 serum biochemical markers
showed significant differences between severe and mild COVID-19 patients. Interestingly, …

… In Tables 1, 2, we compared NLR to other reported markers for COVID-19. We seperated
the variables into those that have been reported for COVID-19 diagnosis and disease severity. …

… -19. The associations of increased ALT, AST, ALP, and TBIL … associated with adverse
outcomes of COVID-19 (Table 2 and … of liver function with 28-day mortality of COVID19 using …

… to test whether severe Coronavirus disease 2019 (COVID-19) is associated with markers of
… approach to analyze plasma samples from COVID-19 patients with varying disease severity …

… after a mild COVID-19, to … mild COVID-19, present higher levels of inflammatory markers
than subjects without PCS. Also, given the sex differences in the immune response to COVID-19…

… , endothelial coronary and myocardial function markers 4 months after COVID-19 infection.
… and myocardial function markers at a longer follow-up period post-COVID-19 infection would …

… with coronavirus disease 2019 (COVID-19) have liver and kidney dysfunction. We aim to
investigate the levels of liver and kidney function indexes in mild and severe COVID-19 patients …

… to be a key factor of COVID-19-associated coagulopathy, markers indicative of this process
… COVID-19, we identified circulating markers that segregated with disease severity: markers of …

… S100B was higher in patients with mild and severe COVID-19 than in healthy controls,
and may be a marker of disease severity (95). Antiphospholipid antibodies (ie, anti-…